| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.42 | 0.002 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |